{"id":7009,"date":"2018-03-29T11:10:42","date_gmt":"2018-03-29T11:10:42","guid":{"rendered":"https:\/\/mda.brandncraft.com\/?p=7009"},"modified":"2026-01-23T14:30:08","modified_gmt":"2026-01-23T14:30:08","slug":"oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain","status":"publish","type":"post","link":"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/","title":{"rendered":"Oncologists\u2019 Usage of Biomarker Testing is Growing, but Opportunities for Increased Use Remain"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

Biomarkers are molecules found in bodily fluids or tissues (including the tumor tissue). They provide valuable information about the cancer cells and non-cancer cells when analyzing which biomarkers are produced in response to the cancer. By developing a biomarker profile of a patient\u2019s cancer, doctors can recommend the best suited treatment plan for their patient.<\/p>\n","protected":false},"author":8,"featured_media":7012,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[15],"tags":[],"country-icon":[45,44],"class_list":["post-7009","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-survey-data-canada","country-icon-canada","country-icon-united-states"],"acf":[],"yoast_head":"\nBiomarker Testing Growth | Oncology Biomarker Testing MD Analytics<\/title>\n<meta name=\"description\" content=\"We asked 32 Canadian Oncologists about biomarker testing growth, opportunities, and the role it plays in their management of cancer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biomarker Testing Growth | Oncology Biomarker Testing MD Analytics\" \/>\n<meta property=\"og:description\" content=\"We asked 32 Canadian Oncologists about biomarker testing growth, opportunities, and the role it plays in their management of cancer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/\" \/>\n<meta property=\"og:site_name\" content=\"MD Analytics\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-29T11:10:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-23T14:30:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2026\/01\/Cancer-Biomarker-Testing.png\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Daniel Turner, VP Client Services\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Daniel Turner, VP Client Services\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/survey-data\\\/survey-data-canada\\\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/survey-data\\\/survey-data-canada\\\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\\\/\"},\"author\":{\"name\":\"Daniel Turner, VP Client Services\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/#\\\/schema\\\/person\\\/218842d011574fcb0bdfc3f3a5bb5e7f\"},\"headline\":\"Oncologists\u2019 Usage of Biomarker Testing is Growing, but Opportunities for Increased Use Remain\",\"datePublished\":\"2018-03-29T11:10:42+00:00\",\"dateModified\":\"2026-01-23T14:30:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/survey-data\\\/survey-data-canada\\\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\\\/\"},\"wordCount\":13,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/survey-data\\\/survey-data-canada\\\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Cancer-Biomarker-Testing.png\",\"articleSection\":[\"Survey Results Canada\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/survey-data\\\/survey-data-canada\\\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/survey-data\\\/survey-data-canada\\\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\\\/\",\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/survey-data\\\/survey-data-canada\\\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\\\/\",\"name\":\"Biomarker Testing Growth | Oncology Biomarker Testing MD Analytics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/survey-data\\\/survey-data-canada\\\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/survey-data\\\/survey-data-canada\\\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Cancer-Biomarker-Testing.png\",\"datePublished\":\"2018-03-29T11:10:42+00:00\",\"dateModified\":\"2026-01-23T14:30:08+00:00\",\"description\":\"We asked 32 Canadian Oncologists about biomarker testing growth, opportunities, and the role it plays in their management of cancer.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/survey-data\\\/survey-data-canada\\\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/survey-data\\\/survey-data-canada\\\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/survey-data\\\/survey-data-canada\\\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Cancer-Biomarker-Testing.png\",\"contentUrl\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Cancer-Biomarker-Testing.png\",\"width\":900,\"height\":500,\"caption\":\"Cancer-Biomarker-Testing\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/survey-data\\\/survey-data-canada\\\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oncologists\u2019 Usage of Biomarker Testing is Growing, but Opportunities for Increased Use Remain\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/\",\"name\":\"MD Analytics\",\"description\":\"Health And Pharmaceutical Market Research | MD Analytics ULC\",\"publisher\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/#organization\",\"name\":\"MD Analytics Inc.\",\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":null,\"contentUrl\":null,\"width\":null,\"height\":null,\"caption\":\"MD Analytics Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/#\\\/schema\\\/person\\\/218842d011574fcb0bdfc3f3a5bb5e7f\",\"name\":\"Daniel Turner, VP Client Services\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Circle-DanT-1-150x150.png\",\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Circle-DanT-1-150x150.png\",\"contentUrl\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Circle-DanT-1-150x150.png\",\"caption\":\"Daniel Turner, VP Client Services\"},\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/en\\\/author\\\/dturner\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biomarker Testing Growth | Oncology Biomarker Testing MD Analytics","description":"We asked 32 Canadian Oncologists about biomarker testing growth, opportunities, and the role it plays in their management of cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/","og_locale":"en_US","og_type":"article","og_title":"Biomarker Testing Growth | Oncology Biomarker Testing MD Analytics","og_description":"We asked 32 Canadian Oncologists about biomarker testing growth, opportunities, and the role it plays in their management of cancer.","og_url":"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/","og_site_name":"MD Analytics","article_published_time":"2018-03-29T11:10:42+00:00","article_modified_time":"2026-01-23T14:30:08+00:00","og_image":[{"width":900,"height":500,"url":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2026\/01\/Cancer-Biomarker-Testing.png","type":"image\/png"}],"author":"Daniel Turner, VP Client Services","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Daniel Turner, VP Client Services","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/#article","isPartOf":{"@id":"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/"},"author":{"name":"Daniel Turner, VP Client Services","@id":"https:\/\/mda.brandncraft.com\/en\/#\/schema\/person\/218842d011574fcb0bdfc3f3a5bb5e7f"},"headline":"Oncologists\u2019 Usage of Biomarker Testing is Growing, but Opportunities for Increased Use Remain","datePublished":"2018-03-29T11:10:42+00:00","dateModified":"2026-01-23T14:30:08+00:00","mainEntityOfPage":{"@id":"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/"},"wordCount":13,"commentCount":0,"publisher":{"@id":"https:\/\/mda.brandncraft.com\/en\/#organization"},"image":{"@id":"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/#primaryimage"},"thumbnailUrl":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2026\/01\/Cancer-Biomarker-Testing.png","articleSection":["Survey Results Canada"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/","url":"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/","name":"Biomarker Testing Growth | Oncology Biomarker Testing MD Analytics","isPartOf":{"@id":"https:\/\/mda.brandncraft.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/#primaryimage"},"image":{"@id":"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/#primaryimage"},"thumbnailUrl":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2026\/01\/Cancer-Biomarker-Testing.png","datePublished":"2018-03-29T11:10:42+00:00","dateModified":"2026-01-23T14:30:08+00:00","description":"We asked 32 Canadian Oncologists about biomarker testing growth, opportunities, and the role it plays in their management of cancer.","breadcrumb":{"@id":"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/#primaryimage","url":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2026\/01\/Cancer-Biomarker-Testing.png","contentUrl":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2026\/01\/Cancer-Biomarker-Testing.png","width":900,"height":500,"caption":"Cancer-Biomarker-Testing"},{"@type":"BreadcrumbList","@id":"https:\/\/mda.brandncraft.com\/en\/survey-data\/survey-data-canada\/oncologists-usage-of-biomarker-testing-is-growing-but-opportunities-for-increased-use-remain\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mda.brandncraft.com\/en\/"},{"@type":"ListItem","position":2,"name":"Oncologists\u2019 Usage of Biomarker Testing is Growing, but Opportunities for Increased Use Remain"}]},{"@type":"WebSite","@id":"https:\/\/mda.brandncraft.com\/en\/#website","url":"https:\/\/mda.brandncraft.com\/en\/","name":"MD Analytics","description":"Health And Pharmaceutical Market Research | MD Analytics ULC","publisher":{"@id":"https:\/\/mda.brandncraft.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mda.brandncraft.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mda.brandncraft.com\/en\/#organization","name":"MD Analytics Inc.","url":"https:\/\/mda.brandncraft.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mda.brandncraft.com\/en\/#\/schema\/logo\/image\/","url":null,"contentUrl":null,"width":null,"height":null,"caption":"MD Analytics Inc."},"image":{"@id":"https:\/\/mda.brandncraft.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/mda.brandncraft.com\/en\/#\/schema\/person\/218842d011574fcb0bdfc3f3a5bb5e7f","name":"Daniel Turner, VP Client Services","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2026\/01\/Circle-DanT-1-150x150.png","url":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2026\/01\/Circle-DanT-1-150x150.png","contentUrl":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2026\/01\/Circle-DanT-1-150x150.png","caption":"Daniel Turner, VP Client Services"},"url":"https:\/\/mda.brandncraft.com\/en\/author\/dturner\/"}]}},"_links":{"self":[{"href":"https:\/\/mda.brandncraft.com\/en\/wp-json\/wp\/v2\/posts\/7009","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mda.brandncraft.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mda.brandncraft.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mda.brandncraft.com\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/mda.brandncraft.com\/en\/wp-json\/wp\/v2\/comments?post=7009"}],"version-history":[{"count":1,"href":"https:\/\/mda.brandncraft.com\/en\/wp-json\/wp\/v2\/posts\/7009\/revisions"}],"predecessor-version":[{"id":7015,"href":"https:\/\/mda.brandncraft.com\/en\/wp-json\/wp\/v2\/posts\/7009\/revisions\/7015"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mda.brandncraft.com\/en\/wp-json\/wp\/v2\/media\/7012"}],"wp:attachment":[{"href":"https:\/\/mda.brandncraft.com\/en\/wp-json\/wp\/v2\/media?parent=7009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mda.brandncraft.com\/en\/wp-json\/wp\/v2\/categories?post=7009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mda.brandncraft.com\/en\/wp-json\/wp\/v2\/tags?post=7009"},{"taxonomy":"country-icon","embeddable":true,"href":"https:\/\/mda.brandncraft.com\/en\/wp-json\/wp\/v2\/country-icon?post=7009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}